FNY Investment Advisers »

Protagenic Therapeutics shares owned by FNY Investment Advisers

Quarter-by-quarter ownership of Protagenic Therapeutics (PTIX) shares owned by FNY Investment Advisers from 13F filings

Historical chart of FNY Investment Advisers investment in Protagenic Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protagenic Therapeutics held by FNY Investment Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagenic Therapeutics by FNY Investment Advisers

Quarter filed Position value Share count Share price at filing
2025-09-30 $60k 18k 3.43

More positions owned by FNY Investment Advisers

Verona Pharma Plc ads (VRNA)
NVIDIA Corporation (NVDA)
UnitedHealth (UNH)
Sibanye Stillwater Adr Rep 4 Ord Sponsored Adr (SBSW)
Copper Property Control Pass-T (CPPTL)
Codere Online Luxembourg Ord (CDRO)
iShares Barclays 20+ Yr Treas.Bond (TLT)
Microsoft Corporation (MSFT)
Fnma 0.000 preferred (FNMFN)
Churchill Cap Corp X
Seagate Technology Com Stk
Futurecrest Acquisition Corp
Sigma Lithium Corporation (SGML)
Taiwan Semiconductor Mnftg Adr 5 Ord Sponsored Adr (TSM)
Boeing Company (BA)

View all positions for FNY Investment Advisers

Top funds holding Protagenic Therapeutics

DRW Holdings
Connective Capital Management
FNY Investment Advisers
Morgan Stanley
Tower Research Capital
UBS Group
CWM
Harbor Investment Advisory

View all funds holding Protagenic Therapeutics